Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial

Published:2018-07-20 Issue:3 Volume:29 Page:452-460
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Tanaka Yoshiya¹,Bass Damon²,Chu Myron²,Egginton Sally³,Ji Beulah⁴,Struemper Herbert⁵,Roth David²

Affiliation:

1. The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan;

2. GlaxoSmithKline, Philadelphia, PA, USA;

3. GlaxoSmithKline, Stevenage, UK;

4. Clinical Development, GlaxoSmithKline R&D, Uxbridge, UK;

5. Quantitative Clinical Development, PAREXEL, Durham, NC, USA

Funder

GSK

Mitsubishi-Tanabe

Takeda

Daiichi-Sankyo

Chugai, Bristol-Myers Squibb

MSD

Astellas

AbbVie

Eisai

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2018.1480915

Reference28 articles.

1. Systemic lupus erythematosus

2. Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus

3. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

4. Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus

5. B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus;Pharmacology Research & Perspectives;2024-08

2. Early add-on use of belimumab as induction therapy for patients with childhood-onset systemic lupus erythematosus;Lupus;2024-03-08

3. Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus;Clinical Rheumatology;2024-02-09

4. Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review;Current Therapeutic Research;2024

5. Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia;International Journal of Rheumatic Diseases;2023-12-23